相关实验视频

Updated: Jan 6, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

非劣等性和效率/收入便利化 (NERF) 终点:改变健康AI论证的依据干预性研究

S S Graham¹, J Shiva Edward², K R Harrison²

¹The University of Texas at Austin, 208 W. 21 st St, STOP B5500, Parlin Hall, Room 3, Austin, TX, 78712, United States of America. ssg@utexas.edu.

Journal of bioethical inquiry

|November 18, 2025

概括

使用非劣势和效率/收入促进 (NERF) 结合终点的新健康AI试验优先考虑经济效益而不是患者健康. 这种转变有可能加快医疗保健的金融化危害,并对患者护理产生负面影响.

科学领域:

医学伦理医学伦理
卫生经济学卫生经济学
人工智能在医学中的应用

背景情况:

人工智能 (AI) 在医疗保健中的整合带来了新的伦理挑战.
综合的非劣势性和效率/收入促进 (NERF) 终点在健康人工智能研究中越来越多地使用.
现有的研究缺乏对NERF终点驱动的论证转移的全面伦理分析.

研究的目的:

研究使用NERF终点的健康AI试验中的论证转移相关的伦理风险.
分析在健康人工智能研究中优先考虑经济利益而不是患者的结果的说服力逻辑和潜在的伦理影响.
评估采用NERF终点对医疗保健和患者福祉金融化的潜在影响.

主要方法:

图尔明的论证分析被用来检查主导的说服逻辑.
对23个健康AI试验进行了定性分析,评估了NERF终点.
该研究的重点是确定采用新型干预措施的证据基础的转变.

主要成果:

NERF终点试验报告显示了论证逻辑的转变.
证据基础从患者健康结果转移到优先考虑经济效益.
这一转变与医疗保健部门的金融化趋势保持一致,并可能加快这一趋势.

结论:

新兴的NERF终点逻辑在健康AI研究中带来了重大伦理风险.
优先考虑经济利益而不是患者利益,可能会导致患者护理的重大损害.
无节制的NERF终点增长可能会加剧对患者健康和福祉的负面影响,需要严格的道德监督.

关键词:

论证理论论证理论是一个论证理论.经济终点经济终点基于证据的医学是基于证据的医学.非劣势性试验的试验.研究伦理研究伦理学

更多相关视频

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Bioequivalence of Drugs: Drugs with Multiple Indications

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...